September 21, 2017 3:31 AM ET

Biotechnology

Company Overview of International Stem Cell Corporation

Executive Profile

Charles J. Casamento MBA

AgeTotal Calculated CompensationThis person is connected to 6 Board Members in 6 organization across 10 different industries.

See Board Relationships
72$67,395

Background

Mr. Charles J. Casamento, also known as Chuck, MBA, has been Principal of The Sage Group, Inc. since May 2007. Mr. Casamento has over 38 years of extensive experience in marketing, business development and Executive management in pharmaceutical, biotechnology and medical products companies. Mr. Casamento served as the President and Chief Executive Officer of Osteologix Holdings plc (alternate name: Osteologix Inc.), from October 18, 2004 to April 3, 2007, Chief Accounting ...

Corporate Headquarters

5950 Priestly Drive
Carlsbad, California 92008

United States

Phone: 760-940-6383
Fax: 760-476-0600

Board Members Memberships

2002-Present
Independent Director
2007-Present
Executive Director
2010-Present
Executive Director
2013-Present
Director
2015-Present
Chairman
2017-Present
Director

Education

BS
Fordham University
MBA
Iona College

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

Total Annual Cash Compensation$32,500
Total Calculated Compensation$67,395
\
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Olav Hellebø MBA, BBACEO & Director
ReNeuron Group plc
$399.0K
Marc H. Hedrick M.D.President, CEO & Director
Cytori Therapeutics, Inc.
$450.0K
David E. Jorden CPAChief Executive Officer, Chief Financial Officer and Executive Director
Nuo Therapeutics, Inc.
$260.4K
Michael Tomas Chief Executive Officer, President, Chief Financial Officer and Director
U.S. Stem Cell, Inc.
$1.2M
Richard J. Daly Chairman of the Board, CEO, President and Interim Principal Financial & Accounting Officer
Neuralstem, Inc.
$551.7K
Compensation as of Fiscal Year 2017.

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact International Stem Cell Corporation, please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.